Allstate Corp Incyte Corp Transaction History

Allstate Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $8,733 - $10,934	130 Added 0.96%	13,620 $1.09 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $7,345 - $9,197	-111 Reduced 0.82%	13,490 $899,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $20,714 - $26,035	-313 Reduced 2.25%	13,601 $1.03 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $31,755 - $38,340	481 Added 3.58%	13,914 $1.11 Million
Q4 2021 Feb 15, 2022	BUY	$63.34 - $74.11 $492,025 - $575,686	7,768 Added 137.12%	13,433 $986,000
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $8,309 - $10,166	-121 Reduced 2.09%	5,665 $390,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $90,173 - $98,821	-1,129 Reduced 16.33%	5,786 $487,000
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $279,905 - $370,041	3,682 Added 113.89%	6,915 $562,000
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $7,024 - $8,499	-87 Reduced 2.62%	3,233 $281,000
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $280,816 - $362,086	-3,301 Reduced 49.86%	3,320 $298,000
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $127,441 - $187,141	1,718 Added 35.04%	6,621 $688,000
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $137,100 - $186,554	2,170 Added 79.4%	4,903 $359,000
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $199,618 - $261,602	2,733 New	2,733 $239,000
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $221,008 - $262,588	-3,035 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $223,133 - $269,204	3,035 New	3,035 $258,000

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.